Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Witkin

Showing results (231-240 of 321) with videos related to

Pageof 33
Sort By:
International Journal of Cancer|September 9, 1992
The study of markers of biological effect in cancer prevention research trialsP Greenwald, K M Witkin, W F Malone, et al.
Journal of Medicinal Chemistry|August 16, 1996
(+/-)-3-[4'-(N,N-dimethylamino)cinnamyl]benzazepine analogs: novel dopamine D1 receptor antagonistsJ H Shah, R H Kline, B Geter-Douglass, et al.
Behavioural Brain Research|November 25, 2018
Effects of 5-HT<sub>7</sub> receptor antagonists on behaviors of mice that detect drugs used in the treatment of anxiety, depression, or schizophreniaJulia Maxwell, Scott D Gleason, Julie Falcone, et al.
Pharmacology & Therapeutics|November 9, 2024
Pharmacological modulation of respiratory control: Ampakines as a therapeutic strategySabhya Rana, Anna F Fusco, Jeffrey M Witkin, et al.
Behavioural Brain Research|September 17, 2016
Consequences of constitutive deletion of melanin-concentrating hormone-1 receptors for feeding and foraging behaviors of miceWilliam J A Eiler, Yanyun Chen, Lawrence J Slieker, et al.
Pharmacology & Therapeutics|February 18, 2024
Mechanistic and therapeutic relationships of traumatic brain injury and γ-amino-butyric acid (GABA)Jeffrey M Witkin, Hana Shafique, Rok Cerne, et al.
Neuropharmacology|April 10, 2007
Anxiolytic-like effects through a GLUK5 kainate receptor mechanismAndrew Alt, Brianne Weiss, Paul L Ornstein, et al.
Molecules (Basel, Switzerland)|June 28, 2023
Synthesis and Receptor Binding Studies of α5 GABA<sub>A</sub>R Selective Novel Imidazodiazepines Targeted for Psychiatric and Cognitive DisordersDishary Sharmin, Md Yeunus Mian, Michael Marcotte, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1995
NMDA antagonist properties of the putative antiaddictive drug, ibogaineP Popik, R T Layer, L H Fossom, et al.
Pharmacology, Biochemistry, and Behavior|February 2, 2025
Amplification of the therapeutic potential of AMPA receptor potentiators from the nootropic era to todayDaniel P Radin, Arnold Lippa, Sabhya Rana, et al.
Pageof 33

Showing results (231-240 of 321) with videos related to

Sort By:
Pageof 33
International Journal of Cancer|September 9, 1992
The study of markers of biological effect in cancer prevention research trialsP Greenwald, K M Witkin, W F Malone, et al.
Journal of Medicinal Chemistry|August 16, 1996
(+/-)-3-[4'-(N,N-dimethylamino)cinnamyl]benzazepine analogs: novel dopamine D1 receptor antagonistsJ H Shah, R H Kline, B Geter-Douglass, et al.
Behavioural Brain Research|November 25, 2018
Effects of 5-HT<sub>7</sub> receptor antagonists on behaviors of mice that detect drugs used in the treatment of anxiety, depression, or schizophreniaJulia Maxwell, Scott D Gleason, Julie Falcone, et al.
Pharmacology & Therapeutics|November 9, 2024
Pharmacological modulation of respiratory control: Ampakines as a therapeutic strategySabhya Rana, Anna F Fusco, Jeffrey M Witkin, et al.
Behavioural Brain Research|September 17, 2016
Consequences of constitutive deletion of melanin-concentrating hormone-1 receptors for feeding and foraging behaviors of miceWilliam J A Eiler, Yanyun Chen, Lawrence J Slieker, et al.
Pharmacology & Therapeutics|February 18, 2024
Mechanistic and therapeutic relationships of traumatic brain injury and γ-amino-butyric acid (GABA)Jeffrey M Witkin, Hana Shafique, Rok Cerne, et al.
Neuropharmacology|April 10, 2007
Anxiolytic-like effects through a GLUK5 kainate receptor mechanismAndrew Alt, Brianne Weiss, Paul L Ornstein, et al.
Molecules (Basel, Switzerland)|June 28, 2023
Synthesis and Receptor Binding Studies of α5 GABA<sub>A</sub>R Selective Novel Imidazodiazepines Targeted for Psychiatric and Cognitive DisordersDishary Sharmin, Md Yeunus Mian, Michael Marcotte, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1995
NMDA antagonist properties of the putative antiaddictive drug, ibogaineP Popik, R T Layer, L H Fossom, et al.
Pharmacology, Biochemistry, and Behavior|February 2, 2025
Amplification of the therapeutic potential of AMPA receptor potentiators from the nootropic era to todayDaniel P Radin, Arnold Lippa, Sabhya Rana, et al.
Pageof 33